Wei Kang, the inheritor of a bankrupt pharmaceutical company, faced a sea of troubles. The company had spent a fortune on developing a new drug, but it failed. The competition was fierce, the bank was pressing for loans, his parents had died in a car accident, and he himself had suddenly contracted
